🔎 Trials Near Me

Akèy › Migrèn › Pennsylvania › Philadelphia

Etid klinik pou Migrèn nan Philadelphia, PA

8 etid pou Migrèn ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

Ap rekriteFaz 1
  • Children's Hospital of Philadelphia, Philadelphia
Laj 6 a 11 · Tout sèks · Mizajou Sep 28, 2026 · NCT06995729

MMA Embolization for Refractory Chronic Migraine

Ap rekrite
  • Thomas Jefferson University Hospital, Philadelphia
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT06735833

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Ap rekriteFaz 3
  • Clario, Philadelphia
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Ap rekriteFaz 3
  • The Children's Hospital of Philadelphia /ID# 270842, Philadelphia
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

Ap rekrite
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours Children's Health System, Wilmington · 25 mi lwen
Laj 10 a 17 · Tout sèks · Mizajou Sep 21, 2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Ap rekriteFaz 4
  • University of Pennsylvania, Philadelphia
Laj 18 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Ap rekriteFaz 3
  • Children's Hospital of Philadelphia - Main /ID# 232487, Philadelphia
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Ap rekriteFaz 3
  • Clinical Research Philadelphia, Philadelphia
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924

Etid Migrèn nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.